The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Tesaro, Inc.

NEW YORK--()--The Klein Law Firm announces the commencement of an investigation of Tesaro, Inc. (NASDAQ: TSRO) concerning possible violations of federal securities laws.

On January 12, 2018, Tesaro announced it had updated the U.S. labeling of VARUBI® (rolapitant) injectable emulsion packages after reports that some patients receiving the treatment experienced “Anaphylaxis, anaphylactic shock and other serious hypersensitivity reactions.”

If you suffered a loss in Tesaro and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/TSRO-Info-Request-Form-245.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

The Klein Law Firm
Joseph Klein, Esq., 212-616-4899
Fax: 347-558-9665
www.kleinstocklaw.com

Release Summary

The Klein Law Firm announces the commencement of an investigation of Tesaro, Inc.

Contacts

The Klein Law Firm
Joseph Klein, Esq., 212-616-4899
Fax: 347-558-9665
www.kleinstocklaw.com